Ardelyx Newsroom

Piper Sandler Maintains Ardelyx(ARDX.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsOct 23 08:31 ET

Piper Sandler Maintains Ardelyx(ARDX.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsOct 3 07:34 ET

Piper Sandler Remains a Hold on Ardelyx (ARDX)

TipRanksOct 3 06:47 ET

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX)

TipRanksSep 4 05:08 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)

TipRanksAug 7 02:06 ET

Ardelyx Analyst Ratings

BenzingaAug 5 13:50 ET

H.C. Wainwright Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $11

Moomoo NewsAug 5 06:31 ET

Ardelyx: Strong Sales Growth and Strategic Expansion Drive Buy Rating

TipRanksAug 5 06:24 ET

Ardelyx Analyst Ratings

BenzingaAug 2 09:08 ET

A Quick Look at Today's Ratings for Ardelyx(ARDX.US), With a Forecast Between $7 to $12

Moomoo NewsAug 2 09:06 ET

Ardelyx's Robust Drug Performance and Growth Potential Warrants a Buy Rating

TipRanksAug 2 07:23 ET

Piper Sandler Gives a Hold Rating to Ardelyx (ARDX)

TipRanksAug 2 07:08 ET

Piper Sandler Downgrades Ardelyx(ARDX.US) to Hold Rating, Cuts Target Price to $7

Moomoo NewsJul 23 07:38 ET

Piper Sandler Sticks to Their Hold Rating for Ardelyx (ARDX)

TipRanksJul 23 06:47 ET

HC Wainwright & Co. Reiterates Buy on Ardelyx, Maintains $10 Price Target

BenzingaJul 18 15:03 ET

Ardelyx Analyst Ratings

BenzingaJul 18 09:44 ET

Wedbush Sticks to Its Buy Rating for Ardelyx (ARDX)

TipRanksJul 18 08:51 ET

Ardelyx's Strategic Response to Regulatory Challenges: A High-Risk Buy Rating With Potential for Substantial Return

TipRanksJul 17 20:42 ET

Ardelyx Analyst Ratings

BenzingaJul 3 14:05 ET

Wedbush Adjusts Ardelyx's Price Target to $11 From $15, Keeps Outperform Rating

MT NewswiresJul 2 12:25 ET